vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - düslipideemiad - lipiidi modifitseerivad ained - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminohapete ainevahetus, kaasasündinud vead - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
braunol nahalahus
b. braun melsungen ag - joodpovidoon - nahalahus - 75mg 1g 100ml 1tk; 75mg 1g 1000ml 1tk
sulfargin salv
grindeks as - hõbesulfadiasiin - salv - 10mg 1g 50g 1tk; 10mg 1g 500g 1tk
alvegesic vet. 10mg/ml süstelahus
v.m.d. - butorfanool - süstelahus - 10mg 1ml 10ml 1tk
sibicort kreem
orion corporation - hüdrokortisoon+kloorheksidiin - kreem - 10mg+10mg 1g 20g 1tk
bepanthen salv
bayer uab - dekspantenool - salv - 50mg 1g 50g 1tk; 50mg 1g 3.5g 1tk; 50mg 1g 30g 1tk
tiasol lahus joogivees manustamiseks
dechra regulatory b.v. - tiamuliin - lahus joogivees manustamiseks - 101,2mg 1ml 5000ml 1tk; 101,2mg 1ml 1000ml 1tk
braunovidon salv
b. braun melsungen ag - joodpovidoon - salv - 100mg 1g 20g 1tk; 100mg 1g 100g 1tk
tiasol lahus joogivees manustamiseks
dechra regulatory b.v. - tiamuliin - lahus joogivees manustamiseks - 202,4mg 1ml 1000ml 1tk; 202,4mg 1ml 5000ml 1tk